Bipolar Disorder (2018) |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
GGT7 MRPS33 |
Bipolar Disorder or Schizophrenia |
1.2 |
9 |
6 |
13.3 |
-0.59 |
9.5e-02 |
BRAF CHRNA3 CUL3 DPP3 GGT7 LOC723809 MAD1L1 MRPS33 ZMAT2 |
Depressed Affect (Nagel 2018) |
1.6 |
9 |
7 |
15.6 |
-0.82 |
2.0e-03 |
ARL17B DCC HORMAD2 LRRC37A2 LRRC37A4P MAPT PTCH1 RNF123 TCF4 |
Depression (Nagel 2018) |
1.4 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARL17B JMJD1C |
Intelligence (Savage-Jansen 2018) |
1.4 |
15 |
12 |
26.7 |
0.57 |
2.1e-02 |
ARFGEF2 ARL17B CENPW DCAF16 EIF3C FOXO3 FOXP1 JMJD1C LRRC37A2 LRRC37A4P MAPT NR2F1 RNF123 SLC25A5P1 ZMAT2 |
Neuroticism (Nagel 2018) |
1.7 |
12 |
7 |
15.6 |
-0.69 |
6.3e-03 |
ACTG1 ARL17B CENPW DIMT1 HORMAD2 LRRC37A2 LRRC37A4P MAPT PTCH1 STX1B TCF4 UBXN2A |
Schizophrenia (2018) |
1.1 |
6 |
1 |
2.2 |
-0.23 |
6.6e-01 |
CHRNA3 CUL3 DCC LOC723809 MAD1L1 ZMAT2 |
Worry (Nagel 2018) |
1.5 |
9 |
6 |
13.3 |
-0.72 |
1.2e-02 |
ARL17B CENPW IQCH LRRC37A2 LRRC37A4P MAPT PTCH1 SEMA3B-AS1 STX1B |
Alzheimer’s Disease (including proxy) |
1.1 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
STX1B |
Crohns Disease (2017) |
1.4 |
10 |
7 |
15.6 |
-0.86 |
7.7e-04 |
CHCHD1 CTSS EIF3C LIME1 P4HA2 PARK7 RTEL1 SDCCAG3 SLC2A4RG STMN3 |
Irritable Bowel Disease (IBD) |
1.5 |
13 |
8 |
17.8 |
-0.78 |
5.7e-04 |
AC016747.3 CERS2 CTSS EIF3C HORMAD2 LIME1 MUC1 P4HA2 PARK7 RTEL1 SDCCAG3 SLC2A4RG STMN3 |
Ulcerative Colitis (UC) |
1.2 |
4 |
3 |
6.7 |
-0.38 |
6.2e-01 |
AC016747.3 PARK7 SDCCAG3 STMN3 |
Major Depression (MDD) |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 |
Reaction Time |
1.3 |
5 |
2 |
4.4 |
-0.71 |
1.1e-01 |
ARL17B DLG4 FOXO3 RMI1 WFIKKN1 |
Verbal and Numeric Reasoning (VNR) |
1.4 |
11 |
7 |
15.6 |
0.60 |
3.8e-02 |
ARFGEF2 DCAF16 EIF3C FOXO3 FOXP1 JMJD1C LRRC37A4P MAPT RNF123 SLC25A5P1 ZMAT2 |
Breast Cancer |
1.5 |
11 |
8 |
17.8 |
-0.22 |
4.7e-01 |
CTC-228N24.3 DIRC3 LRRC37A2 LRRC37A4P MAPT MLLT10 MUC1 PARK7 RIN3 SNUPN SSBP4 |
Ovarian Cancer |
1.4 |
6 |
4 |
8.9 |
0.98 |
1.1e-04 |
CLIC6 HOXB2 LRRC37A2 LRRC37A4P MAPT MLLT10 |
Prostate Cancer |
1.5 |
4 |
2 |
4.4 |
0.16 |
8.4e-01 |
CERS2 LIME1 MDM4 SLC2A4RG |
Age at First Birth |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RNF123 |
Bipolar Disorder (2011) |
2.0 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
DPP3 GGT7 |
Body Mass Index (BMI) (2010) |
1.4 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CDK5RAP3 EIF3C IQCH |
Coronary Artery Disease (CAD) |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CARF TCF21 |
Crohns Disease (2012) |
1.4 |
5 |
4 |
8.9 |
-0.84 |
3.5e-02 |
HORMAD2 P4HA2 SDCCAG3 SLC2A4RG STMN3 |
Mean Putamen Volume |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
HM13 |
HbA1C |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABO |
HDL Cholesterol |
1.2 |
6 |
3 |
6.7 |
-0.27 |
6.1e-01 |
AFF1 ATP6V0D1 C6orf106 JMJD1C PNMT SIDT2 |
LDL Cholesterol |
1.5 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO C6orf106 |
Lupus |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TMEM194B |
Neuroticism (2016) |
1.2 |
4 |
2 |
4.4 |
-0.98 |
3.1e-03 |
LRRC37A2 LRRC37A4P MAPT TCF4 |
Primary Biliary Cirrhosis |
1.1 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CCDC153 LRRC37A4P PNMT |
Rheumatoid Arthritis |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC153 |
Schizophrenia (2014) |
1.1 |
4 |
1 |
2.2 |
0.72 |
2.8e-01 |
CUL3 FOXN2 MAD1L1 RP11-90P5.2 |
Triglycerides |
1.2 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
AFF1 JMJD1C SIDT2 |
Type 2 Diabetes (T2D) (2012) |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
JAZF1 |
Ulcerative Colitis |
1.2 |
5 |
3 |
6.7 |
-0.78 |
1.2e-01 |
LIME1 PARK7 SDCCAG3 SLC2A4RG STMN3 |
Blood Eosinophil Count |
1.3 |
45 |
28 |
62.2 |
0.22 |
1.0e-01 |
AAGAB ABO AC104532.4 ARL17B ATP6V0D1 BANF1 CARF CCDC46 CERS2 CORO7 CRLF3 CTC-228N24.3 CTSS DLG4 EBPL EIF1AD HTR4 IQCH JAZF1 LCT LRRC37A2 LRRC37A4P MAP2K5 MAPT MCM4 MCM6 MRPS21 NFAT5 NOB1 P4HA2 PPARD RIN3 RP11-755F10.1 RP1-244F24.1 RPLP0P2 SDCCAG3 SEMA3B-AS1 SF3B2 SKAP2 SLC2A4RG SLC38A6 SMPD2 SUOX TOM1L2 TSEN2 |
Blood Platelet Count |
1.2 |
64 |
48 |
106.7 |
-0.09 |
4.7e-01 |
ABO ADH1B BIN3 C18orf8 C1orf130 C2orf42 C6orf106 CAB39L CARF CCDC153 CCDC46 CEP120 CERS2 CHRNB1 CHRNG CORO7 CPNE1 CRLF3 CTSS DCAF16 DIMT1 DIP2B DISP2 DSTYK EIF3C EVI2A GFAP GRK4 HM13 JMJD1C LIME1 LMCD1 LRRC37A4P LRRN2 MAPT MSH6 MUC1 P4HA2 PIEZO1 PLAGL2 PNMT PROSER2 RIN3 SAMD4A SCMH1 SEC14L4 SEMA3B-AS1 SIDT2 SLC25A5P1 SLC2A4RG SMG6 SMPD2 SNUPN SSH2 ST7L STMN3 TBPL1 TIGD2 TSEN2 TULP4 VKORC1L1 WFIKKN1 ZNF577 ZNF641 |
Blood Red Count |
1.7 |
63 |
52 |
115.6 |
-0.21 |
8.6e-02 |
ABO AC016725.4 AFF1 AIP AOC1 ARL17B ASPSCR1 B3GNT1 C11orf80 C17orf82 C1orf130 CALM3 CENPW CHP CNIH4 CNTROB CTSF DARS DCXR DOT1L DPP3 DSTYK EIF2AK4 EIF3C GCHFR GSTP1 HM13 HOXB2 JMJD1C KIAA0174 KLRAQ1 LCT LIME1 LRRC37A2 LRRC37A4P LTBP4 MAPT MCM6 MST1P2 MUC1 NFAT5 NOB1 PNMT PSMC5 PYCR1 RIN1 RP11-541N10.3 RPS6KA1 SEMA3B-AS1 SLC25A21 SLC2A4RG SNAI3-AS1 SPRYD4 SSBP4 SSH2 STMN3 STX1B SUPT3H TOM1L2 TSEN2 WFIKKN1 ZBTB4 ZNF641 |
Blood White Count |
1.3 |
57 |
38 |
84.4 |
-0.26 |
4.0e-02 |
ABO AC016747.3 AP4E1 BANF1 BTBD7 C18orf8 C6orf217 CCDC126 CCDC153 CENPW CEP120 CHD7 CLUAP1 CNIH4 CORO7 CTB-36H16.2 CTC-228N24.3 DCAF16 DIP2B DSTYK EIF1AD EIF3C GRK4 HORMAD2 HOXC6 HTR4 JMJD1C KRI1 LEPR LRRC37A2 LRRC37A4P MAP1LC3A MAPT MRPS21 NOB1 NUFIP2 P4HA2 PNMT PPARD PTCH1 RIN3 RMI1 RNF123 RPLP0P2 SCMH1 SDCCAG3 SNUPN SSH2 STMN3 STX1B TNFAIP8 TOM1L2 TULP4 UBXN2A VKORC1L1 ZNF577 ZSWIM7 |
Heel T-Score |
1.9 |
82 |
59 |
131.1 |
0.11 |
2.9e-01 |
AAGAB ABO AFF1 ANAPC10 ANO7P1 AP4E1 ARMS2 ASPSCR1 BMP4 BMP6 C18orf8 CCDC153 CCDC91 CEP120 CHCHD1 CHRNB1 CNIH4 COL21A1 CORO7 CTA-85E5.10 CTB-36H16.2 CTC-228N24.3 CTSS DCAF16 DCXR DIP2B DIRC3 DIS3L2 DOT1L EBPL EEF1G EPB41L2 EYA2 FIP1L1 FLI1 GGT7 GLDN HLX HOXC10 HOXC6 HSPA4 IPO8 IQCH JAG1 KIAA0174 LEAP2 LIME1 LIN28B LRRC37A2 LRRC37A4P MAP1LC3A MAP2K5 MAPT MCM4 MRPL21 MRPS35 MSH6 MUC1 PKDCC RIN3 RIOK1 RP11-250B2.6 RP11-860B13.1 RP11-967K21.1 RPS20 SCMH1 SKAP2 SLC2A4RG SNAI3-AS1 SSBP4 SSH2 ST7L STRA13 STX1B SYT14 TRAF3IP1 TSPAN9 TULP4 TWIST1 WNT4 ZBTB4 ZNF641 |
BMI |
1.7 |
57 |
38 |
84.4 |
-0.35 |
4.2e-03 |
AP3B1 ARFGEF2 BTBD7 C17orf82 C18orf8 C6orf106 CCDC171 CDK5RAP3 CEP120 CHRNB1 CLUAP1 CTD-2201E18.3 CYTL1 DCAF16 DIS3L2 EIF2AK4 EIF3C EML2 FOXO3 FOXP1 GGT7 GRK4 HLX HTR4 IQCH JAZF1 JMJD1C KIAA1598 MAP2K5 MLLT10 MRPL21 MST1P2 NFAT5 NLRC3 NOB1 NOP58 NR2F1 NR3C1 PRKG1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SEMA3B-AS1 SF3B3 SLC25A5P1 SPRYD4 SSH2 STMN3 STRA13 STX1B SUOX SYT14 UBN1 ZCCHC24 ZMAT2 ZSWIM7 |
Height |
3.7 |
178 |
156 |
346.7 |
-0.12 |
9.7e-02 |
AAGAB ABO AC062029.1 ACTG1 AIP ALDH6A1 ANAPC10 AOC1 AP3B1 AP4E1 ARFGEF2 ARL17B ARMS2 ASPSCR1 ATOH7 ATP6V0D1 B3GNT7 BANF1 BMF BMP6 BOK BRAF C10orf11 C17orf82 C18orf8 C2orf42 C2orf54 C6orf106 CARF CCDC126 CCDC87 CCDC91 CDK5RAP3 CENPW CEP120 CHD7 CHP CHRNB1 CHRNG CNIH4 CNTROB COG4 COPS7B CPE CPNE1 CPZ CRLF3 CTA-85E5.10 CTC-228N24.3 CYTL1 DCAF16 DCC DCXR DIP2B DIS3L2 DISP2 DOT1L EBPL EFEMP1 EIF1AD EIF2AK4 EPB41L1 ERC1 EVI2A FAM53A FLI1 FOXN2 FOXO3 GCHFR GFAP GGT7 GLB1 GSTP1 HLX HM13 HORMAD2 IPO8 IQCH ISCA2 JAG1 JAZF1 JMJD1C KLRAQ1 LIME1 LIN28B LLGL2 LMCD1 LRRC37A2 LRRC37A4P LTBP1 LTBP4 MAP1LC3A MAPT MCM4 MDM4 MIF4GD MRPS21 MRPS33 MRPS35 MRPS6 MST1P2 MUC1 NDST1 NDUFB2 NDUFB2-AS1 NFAT5 NOB1 NOL8 NOP58 NR3C1 NUFIP2 P4HA2 PARK7 PBLD PDIK1L PIBF1 PIEZO1 PPIAL4C PRDM11 PROSER2 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB7L1 RAD18 RAVER1 RBBP8 RMI1 RP11-171I2.2 RP11-477D19.2 RP11-529H20.5 RP11-755F10.1 RP11-860B13.1 RP11-90P5.2 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 RRP15 RTEL1 SAMD4A SCMH1 SDCCAG3 SEMA3B-AS1 SENP6 SF3B2 SLC25A21 SLC2A4RG SMAD3 SMG6 SMPD2 SMURF2 SNAI3-AS1 SNUPN SNX13 SSBP4 ST7L STRA13 SUSD5 TBC1D30 TCF4 THBS2 TMTC4 TMUB1 TOM1L2 TRAF3IP1 TSEN2 TULP4 UBXN2A UQCC VKORC1L1 WFIKKN1 WNT4 WWOX ZBTB4 ZNF641 |
Waist Hip Ratio (WHR) |
2.5 |
65 |
44 |
97.8 |
-0.38 |
4.6e-04 |
AAGAB AC004540.4 ANAPC10 AP3B1 ARID5B ASPSCR1 BANF1 C17orf82 CENPW CFHR3 CHRNB1 CNTROB CORO7 CTC-228N24.3 CYTL1 DISP2 DOT1L DSTYK EEF1G EIF1AD EYA2 FLJ12825 GGT7 HLX HOXC10 HOXC6 HSPA4 IQCH JAZF1 LEAP2 LOC723809 LRRC37A2 LRRC37A4P MAP2K5 MAPT MRPS35 MRPS7 MSH6 MST1P2 MUC1 NFAT5 NLRC3 NOL8 NUP85 OPRL1 PLCE1 PSMC5 PYCR1 RAVER1 RP11-23P13.7 RP11-250B2.6 RP11-529H20.5 RP11-64K12.8 SEMA3B-AS1 SF3B2 SNUPN TNFAIP8 TOM1L2 TSEN2 UQCC WNT4 ZBTB4 ZCCHC24 ZNF200 ZSWIM7 |
Systolic Blood Pressure |
1.5 |
52 |
28 |
62.2 |
-0.18 |
1.9e-01 |
AC016725.4 ADAMTS8 ARFGEF2 BMP4 BMP6 C17orf82 CAMK1D CARF CDC123 CEP120 CHP CHRNB1 CLUAP1 COL21A1 CORO7 CTC-228N24.3 DCAF16 DCLK2 DLG4 EFEMP1 EIF2AK4 EPB41L2 FLJ12825 FOXO3 GCHFR HOXC6 HSPA4 HTR4 LIME1 LRRC37A2 LRRC37A4P MAPT NAT15 OPRL1 RIN3 RNF123 RP11-541N10.3 RP11-90P5.2 SF3B3 SIDT2 SLC12A2 SLC2A4RG SMG6 TCF21 TMBIM1 TMEM194B TNFAIP8 UBN1 UBXN2A UQCC ZMAT2 ZNF641 |
Smoking Status |
1.7 |
15 |
1 |
2.2 |
0.46 |
5.6e-02 |
FOXP1 IQCH KIAA1598 MAP1LC3A MAP2K5 MLLT10 MSH6 NUFIP2 PLAGL2 RNF123 SLC25A5P1 SUOX USP14 WFIKKN1 ZFHX3 |
Allergy or Eczema |
1.4 |
14 |
8 |
17.8 |
-0.34 |
2.1e-01 |
BANF1 C6orf106 C6orf217 CTSF EIF1AD GCHFR IQCH JAZF1 LIME1 MRPS33 RIN3 SLC2A4RG STMN3 SUOX |
Cardiovascular Disease |
1.5 |
23 |
9 |
20.0 |
-0.49 |
1.5e-02 |
C17orf82 C18orf8 C1GALT1 CHP CTC-228N24.3 DCAF16 DLG4 GCHFR HOXC6 HTR4 MAP2K5 NFAT5 NOP58 OPRL1 RP11-613D13.5 SF3B3 SIDT2 SLC12A2 STX1B TCF21 TMBIM1 XRN2 ZNF641 |
Hypothyroidism (self reported) |
1.1 |
7 |
5 |
11.1 |
-0.45 |
3.2e-01 |
ARID5B ARMS2 C6orf217 FKBP5 HORMAD2 SUOX TMEM194B |
Respiratory disease |
1.8 |
13 |
10 |
22.2 |
0.08 |
7.6e-01 |
AAGAB C6orf217 CARF CCDC153 IQCH MAP2K5 P4HA2 PNMT RIN3 RNF123 SLC2A4RG STMN3 SUOX |
Type 2 Diabetes (T2D) (2018) |
1.7 |
9 |
6 |
13.3 |
-0.78 |
1.3e-02 |
CAMK1D CENPW EML2 JAZF1 NFAT5 NOB1 RNF123 SNUPN ZCCHC24 |
Lung FEV1/FVC ratio |
2.9 |
73 |
54 |
120.0 |
-0.27 |
1.7e-02 |
ABLIM3 ACTG1 ARID5B ARMS2 ATP6V0D1 BIN3 BMF BMP4 BTBD1 C10orf11 C1GALT1 C6orf106 CAMK1D CARF CCDC171 CDC123 CENPW CEP120 CFHR3 CHCHD1 CHP CHRNA3 CTA-85E5.10 CTC-228N24.3 DSP EFEMP1 EIF2AK4 ERC1 FLJ12825 FOXN2 FOXO3 GPD2 HLX HOXC6 HTR4 INTS12 IQCH ITGA2 JMJD1C KCNQ5 LLGL2 LMCD1 LONRF2 LRRC37A4P LTBP4 MAP1LC3A MICAL3 MLLT10 MRPS35 MRPS6 MST1P2 P4HA2 PAIP1 PAK6 PTCH1 RAB7L1 RMI1 RP11-23P13.7 RPS20 RRP15 SLC38A6 SLMAP SMURF2 SOGA2 SSH2 STARD10 STRA13 SUOX TIGD2 TMUB1 TRAF3IP1 ZFHX3 ZFP14 |
Neuroticism |
1.8 |
13 |
8 |
17.8 |
-0.82 |
9.2e-05 |
AAGAB ACTG1 ARL17B CENPW HORMAD2 IQCH LRRC37A2 LRRC37A4P MAP2K5 MAPT PTCH1 TCF4 UBXN2A |
Chronotype (morning person) |
1.4 |
6 |
6 |
13.3 |
-0.56 |
1.9e-01 |
CERS2 MRPS21 SDCCAG3 SEMA3B-AS1 SLC25A5P1 TRAF3IP1 |
Hair Pigment |
0.7 |
36 |
26 |
57.8 |
0.43 |
5.2e-03 |
ACTG1 AIP ASPSCR1 BRAF BTBD1 C11orf80 C2orf42 C6orf106 CCDC57 CDK5RAP3 CPNE1 CTC-228N24.3 DCXR DSTYK EPB41L1 FOXO3 GGT7 HM13 JAZF1 LRRN2 MAP1LC3A MAPT MRPL21 MSH6 NNT PIEZO1 PYCR1 RP4-614O4.11 SNAI3-AS1 SSBP4 STRA13 TBC1D30 TULP4 TWIST1 UQCC ZCCHC24 |
Tanning |
1.0 |
17 |
13 |
28.9 |
-0.54 |
2.0e-02 |
ACTG1 CERS2 CORO7 CPNE1 CTSS DSTYK EPB41L1 GGT7 JAZF1 MAP1LC3A NOX4 PIEZO1 PLAGL2 RP11-64K12.8 RP4-614O4.11 SNAI3-AS1 UQCC |
Hand grip strength (left) |
2.4 |
31 |
18 |
40.0 |
0.37 |
3.5e-02 |
AC016725.4 AOC1 ARFGEF2 ARL17B BANF1 BRAF CCDC87 DARS DCAF16 DOT1L FOXP1 GFAP HOXB2 JAG1 LIN28B LRRC37A2 LRRC37A4P MAP1LC3A MAPT NFAT5 NOB1 P4HA2 PKDCC PSMC5 RAB7L1 RP11-171I2.2 RP4-614O4.11 STX1B TCF4 UQCC WDR18 |
Number of treatments/medications taken |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MLLT10 RNF123 |
Sensitivity / hurt feelings |
1.5 |
5 |
5 |
11.1 |
-0.81 |
2.7e-02 |
ARL17B LRRC37A2 LRRC37A4P MAPT PTCH1 |
Frequency of depressed mood in last 2 weeks |
1.4 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A2 |
Hearing difficulty/problems: Yes |
1.3 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABLIM3 |
Relative age of first facial hair |
1.8 |
10 |
5 |
11.1 |
-0.81 |
2.8e-03 |
CCDC46 CHRNG FOXO3 GGT7 LIN28B LRRC37A2 LRRC37A4P MAPT SEMA3B-AS1 TWIST1 |
Ever used hormone-replacement therapy (HRT) |
1.0 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
BCDIN3D |
Systolic blood pressure, automated reading |
1.5 |
25 |
14 |
31.1 |
0.02 |
9.4e-01 |
AC016725.4 ADAMTS8 C17orf82 CAMK1D CHRNB1 COL21A1 CTC-228N24.3 DCAF16 DLG4 EIF2AK4 GCHFR HTR4 LRRC37A2 LRRC37A4P MAPT NAT15 OPRL1 PRDM11 RP11-541N10.3 SLC12A2 SLC2A4RG SMG6 STMN3 TMEM194B UBXN2A |
Angina |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCF21 |
Medication for hormone replacement therapy |
1.0 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP1-199J3.5 |
Medication: Metformin |
1.5 |
4 |
2 |
4.4 |
-1.00 |
1.9e-03 |
CAMK1D JAZF1 SNUPN ZCCHC24 |
Diabetes (mother) |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CAMK1D |
Pack years adult smoking proportion |
1.7 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 JMJD1C |
Impedance of leg (right) |
2.3 |
56 |
36 |
80.0 |
-0.25 |
5.3e-02 |
ABO AOC1 AP3B1 C11orf80 C6orf106 CEP120 CLUAP1 CPNE1 CTC-228N24.3 CTSF CTSS DIP2B DPP3 EIF3C EML2 EPB41L1 FLJ12825 GGT7 GLB1 HLX HOXC6 JAZF1 JPH2 LIN28B LRRC37A4P LTBP1 MAP1LC3A MRPL21 MST1P2 MUC1 NLRC3 NOL8 PIAS1 PLCE1 PSMC5 RAVER1 RIN1 RIN3 RNF123 RP11-23P13.7 RP11-90P5.2 RP4-614O4.11 RPS20 SEMA3B-AS1 SLC12A2 SLC2A4RG SMG6 SNAI3-AS1 STX1B SUOX SUPT3H TOM1L2 UQCC WNT4 ZNF641 ZSWIM7 |
Leg fat-free mass (left) |
2.7 |
66 |
47 |
104.4 |
-0.14 |
2.4e-01 |
ACTG1 ANAPC10 AOC1 AP3B1 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CDK5RAP3 CENPW CEP120 CHP CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 GLB1 HORMAD2 IPO8 IQCH KIAA1598 MAP1LC3A MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SLC12A2 SMPD2 STX1B SUOX SUPT3H TULP4 UQCC WNT4 ZSWIM7 |
Trunk fat percentage |
2.1 |
48 |
31 |
68.9 |
-0.28 |
3.9e-02 |
AAGAB AC016725.4 AIP AP3B1 ARL17B C18orf8 C6orf106 CCDC171 CDK5RAP3 CENPW CHRNB1 DARS DIP2B EEF1G EFEMP1 EIF3C FKBP5 FOXO3 FOXP1 GFPT1 GRK4 GSTP1 HOXC6 HTR4 IQCH KIAA1598 LCT LIME1 LRRC37A2 LRRC37A4P MAP2K5 MAPT MCM6 MLLT10 NFAT5 NOB1 PPARD PYGB RIN3 RMI1 RP11-613D13.5 RP1-283E3.4 SLC2A4RG SMAD3 SSH2 ST7L STX1B SYT14 |
Hand grip strength (right) |
2.4 |
29 |
14 |
31.1 |
0.25 |
1.8e-01 |
AC016725.4 AOC1 ARFGEF2 ARL17B CHRNB1 CPNE1 DARS DCAF16 DOT1L EIF3C GFAP HOXB2 JAG1 LIN28B LRRC37A2 LRRC37A4P MAP1LC3A MAPT NFAT5 NOB1 P4HA2 PSMC5 RAB7L1 RP11-171I2.2 RP11-317J10.2 RP4-614O4.11 SCMH1 TULP4 UQCC |
Current tobacco smoking |
1.3 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CARF CUL3 STMN3 |
Fed-up feelings |
1.4 |
4 |
4 |
8.9 |
-0.85 |
7.0e-02 |
DCC LRRC37A2 LRRC37A4P MAPT |
Relative age voice broke |
1.6 |
7 |
4 |
8.9 |
-0.60 |
8.9e-02 |
FOXO3 LIN28B LRRC37A2 LRRC37A4P MAPT SCMH1 UQCC |
Taking other prescription medications |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RNF123 |
Age when periods started (menarche) |
2.0 |
14 |
9 |
20.0 |
-0.24 |
3.3e-01 |
AC016747.3 CENPW CHP FOXO3 GGT7 IQCH LIN28B MAP2K5 MSH6 NFAT5 NOB1 RAVER1 RP11-422P24.10 SEMA3B-AS1 |
Bilateral oophorectomy (both ovaries removed) |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
WNT4 |
Heel bone mineral density (BMD) T-score, automated (left) |
1.5 |
6 |
3 |
6.7 |
-0.04 |
9.5e-01 |
BMP4 EBPL GGT7 PKDCC ST7L WNT4 |
High blood pressure |
1.5 |
10 |
4 |
8.9 |
-0.27 |
4.5e-01 |
CHRNB1 DCAF16 DLG4 GCHFR HOXC6 HTR4 MAP2K5 NAT15 OPRL1 STX1B |
Hayfever, allergic rhinitis or eczema |
1.3 |
8 |
2 |
4.4 |
-0.45 |
2.3e-01 |
C6orf106 C6orf217 GCHFR MRPS33 P4HA2 RIN3 STMN3 SUOX |
Medication: Levothyroxine sodium |
1.1 |
4 |
2 |
4.4 |
-0.99 |
1.1e-02 |
C6orf217 FKBP5 HORMAD2 SUOX |
Sitting height |
3.7 |
102 |
83 |
184.4 |
0.03 |
7.6e-01 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARID3B ARL17B ASPSCR1 ATOH7 BMP6 BOK C18orf8 C6orf106 CCDC126 CCDC171 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 CNTROB COG4 COPS7B CORO7 CPE CPNE1 CPZ CRLF3 DCAF16 DCC DCXR DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EPB41L1 ERC1 EYA2 FAM53A FOXO3 GFAP GGT7 GLB1 HM13 HORMAD2 JAG1 JAZF1 LRRC37A2 LRRC37A4P LTBP1 MAP1LC3A MAPT MRPS21 MST1P2 NDUFB2 NFAT5 NOB1 P4HA2 PARK7 PBLD PDIK1L PKDCC PLAGL2 PROSER2 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB7L1 RP11-171I2.2 RP11-250B2.6 RP11-529H20.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 RRP15 SAMD4A SCMH1 SDCCAG3 SENP6 SLC25A21 SMAD3 SMPD2 SNAI3-AS1 SNUPN SNX13 SUPT3H TBC1D30 TULP4 UBXN2A UQCC WFIKKN1 WNT4 ZBTB4 ZNF438 ZNF641 ZSWIM7 |
Chronic bronchitis/emphysema (father) |
1.5 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 IQCH |
High blood pressure (mother) |
1.3 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
FLJ12825 |
Body mass index (BMI) |
1.6 |
36 |
20 |
44.4 |
-0.67 |
6.4e-06 |
AC016725.4 AP3B1 ARFGEF2 BTBD7 C18orf8 C6orf106 CALML6 CCDC171 CCDC87 CDK5RAP3 CLUAP1 DCAF16 EIF3C FOXO3 FOXP1 GGT7 GRK4 HTR4 IQCH JAZF1 JMJD1C KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NLRC3 NOB1 RNF123 RP11-613D13.5 RP1-283E3.4 STX1B SUOX SYT14 ZSWIM7 |
Impedance of leg (left) |
2.4 |
54 |
38 |
84.4 |
-0.19 |
1.6e-01 |
ABO AOC1 AP3B1 C11orf80 C6orf106 CEP120 CLUAP1 CPNE1 CTC-228N24.3 CTSF CTSS DIP2B DPP3 EIF3C EML2 EPB41L1 FLJ12825 GGT7 GLB1 HLX HOXC6 JAZF1 JPH2 LIME1 LRRC37A2 LRRC37A4P LTBP1 MAP1LC3A MRPL21 MST1P2 MUC1 NFAT5 NLRC3 NOL8 PIAS1 PSMC5 RAVER1 RIN1 RIN3 RNF123 RP11-90P5.2 RP4-614O4.11 RPS20 SEMA3B-AS1 SLC12A2 SLC29A2 SLC2A4RG STX1B SUOX SUPT3H TOM1L2 UQCC WNT4 ZNF641 |
Leg predicted mass (left) |
2.7 |
65 |
47 |
104.4 |
-0.14 |
2.7e-01 |
ACTG1 ANAPC10 AOC1 AP3B1 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CDK5RAP3 CENPW CEP120 CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 GLB1 HORMAD2 IPO8 IQCH KIAA1598 MAP1LC3A MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SLC12A2 SMPD2 STX1B SUOX SUPT3H TULP4 UQCC WNT4 ZSWIM7 |
Trunk fat mass |
2.1 |
48 |
33 |
73.3 |
-0.38 |
4.4e-03 |
AAGAB AC016725.4 AIP ANAPC10 AP3B1 C18orf8 C6orf106 CCDC171 CDK5RAP3 CEP120 CTD-2201E18.3 DLG4 EFEMP1 EIF2AK4 EIF3C EPB41L1 FKBP5 FOXO3 FOXP1 GGT7 GSTP1 HTR4 IQCH KIAA1598 LCT LIN28B LRRC37A2 MAP1LC3A MAP2K5 MAPT MCM6 MLLT10 NFAT5 NOB1 NR3C1 PPARD PYGB RNF123 RP11-613D13.5 RP11-967K21.1 RP1-283E3.4 SLC2A4RG SMAD3 SSH2 ST7L STX1B SYT14 UQCC |
Waist circumference |
1.9 |
36 |
24 |
53.3 |
-0.48 |
1.6e-03 |
AAGAB AC004540.4 AIP AP3B1 BTBD7 C18orf8 C6orf106 CALML6 CCDC171 CDK5RAP3 CEP120 CPNE1 DLG4 EIF3C EPB41L1 FOXO3 GGT7 GRK4 GSTP1 HOXC6 HTR4 IQCH KIAA1598 MAP2K5 MLLT10 NFAT5 NOB1 NR3C1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SLC2A4RG STX1B SYT14 ZCCHC24 |
Number of incorrect matches in round |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
AC016725.4 STX1B |
Past tobacco smoking |
1.7 |
6 |
3 |
6.7 |
-0.83 |
8.1e-04 |
GGT7 IQCH MAP1LC3A MAP2K5 MSH6 NOB1 |
Alcohol usually taken with meals |
1.4 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNB1 FOXP1 |
Nervous feelings |
1.6 |
4 |
3 |
6.7 |
-0.99 |
4.8e-04 |
CENPW LRRC37A2 LRRC37A4P MAPT |
Frequency of tenseness / restlessness in last 2 weeks |
1.4 |
5 |
4 |
8.9 |
-0.99 |
2.9e-05 |
ARL17B LRRC37A2 LRRC37A4P MAPT RNF123 |
Hearing difficulty/problems with background noise |
1.3 |
4 |
0 |
0.0 |
-0.76 |
2.4e-01 |
LIN28B LRRC37A2 LRRC37A4P MAPT |
Hair/balding pattern: Pattern 2 |
1.6 |
6 |
3 |
6.7 |
-0.53 |
2.8e-01 |
C10orf11 CCDC46 CENPW LRRC37A2 LRRC37A4P TWIST1 |
Forced vital capacity (FVC) |
5.6 |
152 |
96 |
213.3 |
0.93 |
1.6e-76 |
AAGAB ABLIM3 ABO AC016725.4 AC073834.3 AC079742.4 AC104532.4 ANAPC10 ANGPTL1 AOC1 AP3B1 AP4E1 APOC1P1 ARFGEF2 ARID3B ARID5B ARL17B ARMS2 ASPSCR1 BANF1 BCDIN3D BMF BOK BRAF BTBD1 C10orf11 C2orf42 C2orf54 C6orf217 CAMK1D CARF CCDC126 CCDC171 CCDC87 CDC123 CENPW CEP120 CHCHD1 CHRNA3 CLIC6 CLUAP1 COG4 CPE CTA-85E5.10 CTB-36H16.2 CTC-228N24.3 CTSS CUL3 DARS DCAF16 DCXR EBPL EEF1G EFEMP1 EIF1AD EIF2AK4 EML2 EPB41L2 ERC1 EYA2 FOXN2 FOXP1 GFAP GOLGA6L9 GRK4 HORMAD2 HS2ST1 HTR4 IGFBP7 INTS12 IPO8 IQCH JAG1 KDR LCT LIME1 LMCD1 LONRF2 LRPAP1 LRRC37A2 LRRC37A4P LTBP4 MAP2 MAP2K5 MAPT MCM6 MDM4 METTL22 MLLT10 MRPL21 MRPS35 MST1P2 MUC1 NDUFB2 NDUFB2-AS1 NFAT5 NLRC3 NOB1 NOP58 NOX4 PDIK1L PKDCC PNMT PPARD PPIAL4C PRDM11 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB3IL1 RAVER1 RIN3 RNF123 RP11-250B2.6 RP11-541N10.3 RP11-64K12.8 RP11-967K21.1 RPS20 RPS6KA1 RRP15 SCMH1 SEC14L1 SENP6 SF3B2 SHROOM3 SLC12A2 SLC25A21 SLC2A4RG SLMAP SMG7 SMPD2 SMURF2 SNAI3-AS1 SNUPN SSH2 STMN3 STX1B SUSD5 TBC1D30 TCP11L1 THBS2 TULP4 UBXN2A UQCC USP14 WDR18 WNT4 ZCCHC24 ZMAT2 ZNF438 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.5 |
5 |
4 |
8.9 |
0.64 |
2.4e-01 |
BMP4 HOXC10 PKDCC ST7L WNT4 |
Ever unenthusiastic/disinterested for a whole week |
1.2 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRRC37A2 LRRC37A4P ZMAT2 |
Qualifications: None of the above |
1.3 |
7 |
5 |
11.1 |
0.32 |
4.4e-01 |
BCDIN3D EIF3C FOXO3 FOXP1 JMJD1C RNF123 SUOX |
Mouth/teeth dental problems |
1.3 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
LCT MCM6 |
Heart attack |
1.3 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF21 TOM1L2 |
Allergy |
1.5 |
15 |
8 |
17.8 |
0.09 |
7.2e-01 |
AAGAB ABO C6orf106 CCDC153 CHP GCHFR IQCH JAZF1 LIME1 MAP2K5 P4HA2 RIN3 SLC2A4RG STMN3 SUOX |
Diabetes (self-reported) |
1.7 |
6 |
2 |
4.4 |
-0.99 |
3.8e-06 |
CAMK1D CTC-228N24.3 JAZF1 NFAT5 SNUPN ZCCHC24 |
Medication: Simvastatin |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO OPRL1 |
Fluid intelligence score |
1.3 |
5 |
4 |
8.9 |
0.70 |
1.2e-01 |
DCAF16 EIF3C FOXO3 FOXP1 RNF123 |
Illnesses of siblings |
1.2 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STX1B |
Neuroticism score |
1.6 |
11 |
6 |
13.3 |
-0.86 |
1.4e-04 |
ARL17B HORMAD2 LRRC37A2 LRRC37A4P MAPT PTCH1 RNF123 SEMA3B-AS1 TCF4 UBN1 UBXN2A |
Weight |
2.2 |
65 |
40 |
88.9 |
-0.34 |
3.8e-03 |
AAGAB AIP ANAPC10 AP3B1 ARMS2 BOK BTBD7 C17orf82 C18orf8 C6orf106 CCDC171 CDK5RAP3 CENPW CEP120 CHRNG COPS7B CPNE1 CRLF3 DCAF16 DOT1L EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 GSTP1 HTR4 IQCH KIAA1598 LCT MAP1LC3A MAP2K5 MCM6 MLLT10 MRPL21 MUC1 NFAT5 NR2F1 NR3C1 P4HA2 PARK7 PSMC5 PYGB RAB7L1 RNF123 RP11-613D13.5 RP11-967K21.1 RP1-283E3.4 RP4-614O4.11 RPS20 SCMH1 SENP6 SLC25A5P1 SLC2A4RG SMPD2 STX1B SUOX SYT14 UQCC WNT4 ZMAT2 ZSWIM7 |
Impedance of arm (right) |
1.7 |
46 |
38 |
84.4 |
-0.08 |
5.9e-01 |
AOC1 ARL17B C6orf106 CENPW CEP120 CERS2 CPNE1 CPZ CTSS DIP2B EEF1G EFEMP1 EVI2A FOXO3 GGT7 HLX HOXC6 JAZF1 JMJD1C LIME1 LIN28B LRPAP1 LRRC37A2 LRRC37A4P MAP1LC3A MAPT MLLT10 MST1P2 MUC1 NOL8 NUFIP2 PIAS1 PSMC5 RAVER1 RIN3 RMI1 RNF123 RPS20 SCMH1 SEMA3B-AS1 SLC2A4RG SMAD3 ST7L STX1B SUOX ZNF641 |
Arm fat percentage (right) |
1.9 |
41 |
26 |
57.8 |
-0.41 |
4.4e-03 |
AAGAB ABO AC016725.4 AP3B1 ARFGEF2 C17orf82 C18orf8 C6orf106 CARF CCDC171 CCDC87 CDK5RAP3 CENPW CHRNB1 DCAF16 DLG4 EIF3C FKBP5 FOXP1 GRK4 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 NOP58 PPARD PYGB RNF123 RP11-613D13.5 RP11-967K21.1 RP1-283E3.4 SLC2A4RG SMAD3 SSH2 STX1B SYT14 |
Trunk fat-free mass |
3.0 |
81 |
65 |
144.4 |
-0.20 |
6.3e-02 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 B3GNT7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 CNTROB COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 HORMAD2 IPO8 JAZF1 LIN28B MAP1LC3A MRPL21 MST1P2 MUC1 NDUFB2 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 QSOX2 RAB7L1 RAVER1 RIN3 RNF123 RP11-477D19.2 RP11-529H20.5 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNAI3-AS1 SNUPN SNX13 SUOX TBC1D30 TULP4 UBXN2A UQCC WNT4 ZBTB4 |
Hip circumference |
1.9 |
49 |
33 |
73.3 |
-0.43 |
1.3e-03 |
AC016725.4 ANAPC10 AP3B1 BOK BTBD7 C18orf8 C2orf54 C6orf106 CCDC171 CDK5RAP3 CEP120 CPNE1 CRLF3 DCXR DLG4 DOT1L EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A EYA2 FAM53A FOXO3 GGT7 HTR4 IQCH KIAA1598 MAP1LC3A MAP2K5 MLLT10 NFAT5 NLRC3 NOB1 NR3C1 RNF123 RP11-613D13.5 RP11-967K21.1 RP1-283E3.4 SENP6 SLC2A4RG SMAD3 STMN3 STX1B SYT14 UQCC WNT4 ZMAT2 ZSWIM7 |
Alcohol intake versus 10 years previously |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
LEAP2 |
Father's age at death |
1.1 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 |
Worrier / anxious feelings |
1.3 |
5 |
4 |
8.9 |
-0.69 |
1.3e-01 |
LRRC37A2 LRRC37A4P MAPT PTCH1 TCF4 |
Hair/balding pattern: Pattern 3 |
1.7 |
7 |
5 |
11.1 |
0.68 |
4.3e-02 |
ARL17B CENPW LRRC37A2 LRRC37A4P MAP1LC3A MAPT TWIST1 |
Number of live births |
1.4 |
4 |
1 |
2.2 |
-0.93 |
7.3e-02 |
KIAA1598 LRRC37A4P WNT4 ZFP14 |
Forced expiratory volume in 1-second (FEV1) |
5.0 |
108 |
75 |
166.7 |
0.94 |
1.0e-60 |
ABLIM3 ABO AC016725.4 AC073834.3 AC104532.4 ANAPC10 ANGPTL1 AOC1 AP3B1 APOC1P1 ARFGEF2 ARID3B ARL17B ASPSCR1 BOK BRAF BTBD1 C10orf11 C1GALT1 C2orf42 C6orf217 CAMK1D CCDC126 CCDC171 CCDC87 CDC123 CENPW CEP120 CHCHD1 CHRNA3 CLUAP1 COG4 CTA-85E5.10 CTB-36H16.2 CTSS DARS DCAF16 DCXR EBPL EEF1G EFEMP1 EIF1AD FOXP1 GOLGA6L9 GPD2 GRK4 HORMAD2 HSPA4 HTR4 IGFBP7 INTS12 IPO8 JAG1 LLGL2 LONRF2 LRPAP1 LRRC37A2 LRRC37A4P MAPT MCM6 MDM4 MICAL3 MRPL21 MST1P2 NDUFB2 NFAT5 NOB1 PDIK1L PKDCC PLAGL2 PPARD PPIAL4C PRDM11 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB3IL1 RIN3 RNF123 RP11-541N10.3 RP11-967K21.1 RPS6KA1 SCMH1 SF3B2 SF3B3 SH3RF1 SLC25A21 SLC2A4RG SLMAP SMG7 SMPD2 SMURF2 SNAI3-AS1 SNUPN SOGA2 STMN3 STX1B SUOX SUSD5 TBC1D30 TCP11L1 THBS2 TULP4 UBXN2A WNT4 ZCCHC24 |
Pulse rate |
1.1 |
4 |
3 |
6.7 |
-0.53 |
4.7e-01 |
B3GNT7 CEP120 TCF21 TOM1L2 |
Qualifications: A levels/AS levels or equivalent |
1.3 |
5 |
3 |
6.7 |
0.50 |
3.1e-01 |
GPD2 JMJD1C LRRC37A4P RNF123 UQCC |
Mouth/teeth dental problems: Dentures |
1.3 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CHRNA3 EIF2AK4 MUC1 |
Asthma |
1.7 |
10 |
7 |
15.6 |
0.06 |
8.6e-01 |
AAGAB HTR4 IQCH MAP2K5 P4HA2 PNMT RIN3 SLC2A4RG STMN3 SUOX |
Medication: Ibuprofen (e.g. Nurofen) |
1.1 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A4P MAPT |
Medication: Cholesterol lowering |
1.2 |
4 |
1 |
2.2 |
-0.99 |
6.0e-03 |
ABO NOP58 OPRL1 SIDT2 |
Lung cancer (father) |
1.3 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 |
Forced expiratory volume in 1-second (FEV1), Best measure |
4.8 |
102 |
66 |
146.7 |
0.94 |
1.5e-53 |
ABLIM3 ABO AC073834.3 ANAPC10 ANGPTL1 AOC1 AP3B1 AP4E1 ARFGEF2 ARL17B ASPSCR1 BOK BRAF BTBD1 C10orf11 C1GALT1 C2orf54 CAMK1D CCDC126 CCDC87 CDC123 CENPW CEP120 CHCHD1 CHRNA3 CLUAP1 COG4 CTA-85E5.10 CTB-36H16.2 CTSS DARS DCAF16 DCXR EBPL EEF1G EFEMP1 FKBP5 FOXP1 GFAP GOLGA6L9 GRK4 HORMAD2 HSPA4 HTR4 INTS12 IPO8 JAG1 LLGL2 LONRF2 LRPAP1 LRRC37A2 LRRC37A4P LTBP4 MAPT MCM6 MDM4 MICAL3 MRPL21 MST1P2 NFAT5 NOB1 PAIP1 PDIK1L PKDCC PLAGL2 PNMT PPARD PPIAL4C PRDM11 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB3IL1 RIN3 RNF123 RP1-137D17.1 RP11-967K21.1 RP4-614O4.11 RPS6KA1 SCMH1 SH3RF1 SLC25A21 SLC2A4RG SLMAP SMG7 SMPD2 SMURF2 SNAI3-AS1 SNUPN SOGA2 STX1B SUOX TBC1D30 TCP11L1 THBS2 TULP4 UBXN2A WNT4 ZCCHC24 ZMAT2 |
Impedance of arm (left) |
1.7 |
48 |
37 |
82.2 |
-0.04 |
8.0e-01 |
AOC1 ARL17B C18orf8 CENPW CEP120 CERS2 CPNE1 CPZ CTSS DIP2B EEF1G EFEMP1 EVI2A FOXO3 GGT7 HLX HOXC10 HOXC6 JAZF1 JMJD1C LIME1 LIN28B LRRC37A2 LRRC37A4P MAP1LC3A MAPT MLLT10 MST1P2 MUC1 NOL8 NUFIP2 PIAS1 PNMAL1 PSMC5 RAVER1 RIN3 RMI1 RNF123 RP11-529H20.5 RPS20 SAMD4A SCMH1 SEMA3B-AS1 SLC2A4RG SMAD3 STX1B SUOX ZNF641 |
Arm fat mass (right) |
1.8 |
37 |
24 |
53.3 |
-0.58 |
6.7e-05 |
AAGAB AC016725.4 AP3B1 C18orf8 C6orf106 CCDC171 CCDC87 CDK5RAP3 CEP120 CLUAP1 DLG4 EIF3C EPB41L1 FOXO3 FOXP1 GGT7 GRK4 HTR4 IQCH KIAA1598 LCT MAP1LC3A MAP2K5 MCM6 MLLT10 NFAT5 NLRC3 NOB1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SSH2 STX1B SYT14 UQCC ZSWIM7 |
Trunk predicted mass |
3.0 |
81 |
65 |
144.4 |
-0.20 |
6.3e-02 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 B3GNT7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 CNTROB COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 HORMAD2 IPO8 JAZF1 LIN28B MAP1LC3A MRPL21 MST1P2 MUC1 NDUFB2 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 QSOX2 RAB7L1 RAVER1 RIN3 RNF123 RP11-477D19.2 RP11-529H20.5 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNAI3-AS1 SNUPN SNX13 SUOX TBC1D30 TULP4 UBXN2A UQCC WNT4 ZBTB4 |
Standing height |
3.6 |
130 |
109 |
242.2 |
-0.15 |
6.9e-02 |
AAGAB AC062029.1 ACTG1 AIP ALDH6A1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARL17B ARMS2 ATOH7 B3GNT7 BANF1 BMP6 BOK BRAF C17orf82 C18orf8 C6orf106 CCDC126 CCDC87 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 CNTROB COG4 COPS7B CPNE1 CPZ CRLF3 CYTL1 DCAF16 DIP2B DIS3L2 DISP2 DOT1L EBPL EFEMP1 EIF1AD EIF2AK4 EPB41L1 ERC1 EVI2A FAM53A FLI1 FOXO3 GCHFR GFAP GGT7 GLB1 GRK4 GSTP1 HLX HM13 HORMAD2 IPO8 ISCA2 JAG1 JAZF1 LIN28B LLGL2 LRRC37A2 LRRC37A4P LTBP1 MAP1LC3A MAPT MCM4 MRPS35 MRPS6 MST1P2 NDUFB2 NDUFB2-AS1 NFAT5 NOB1 NOL8 NOP58 NR3C1 P4HA2 PARK7 PBLD PDIK1L PIBF1 PIEZO1 PROSER2 PSMC5 PTCH1 PYCR1 QSOX2 RAB7L1 RBBP8 RMI1 RP11-171I2.2 RP11-477D19.2 RP11-529H20.5 RP11-860B13.1 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 RRP15 SAMD4A SCMH1 SDCCAG3 SEMA3B-AS1 SENP6 SF3B2 SMAD3 SMPD2 SMURF2 SNAI3-AS1 SNUPN SNX13 STRA13 SUSD5 TBC1D30 TMTC4 TRAF3IP1 TSEN2 TULP4 UBXN2A UQCC WFIKKN1 WNT4 ZBTB4 ZNF641 |
Exposure to tobacco smoke at home |
1.0 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 |
Tense / 'highly strung' |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
SEMA3B-AS1 STX1B |
Seen doctor (GP) for nerves, anxiety, tension or depression |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CCDC87 TCF4 |
Hair/balding pattern: Pattern 4 |
2.5 |
14 |
8 |
17.8 |
0.41 |
1.2e-01 |
ARL17B C10orf11 C2orf42 CCDC46 CENPW CTB-36H16.2 DIP2B IQCH LRRC37A2 LRRC37A4P MAPT SMG6 SUPT3H TWIST1 |
Birth weight of first child |
1.7 |
10 |
4 |
8.9 |
0.73 |
4.4e-03 |
ANAPC10 CTC-228N24.3 DCAF16 DCXR DLG4 FKBP5 HKDC1 IPO8 SLC12A2 WNT4 |
Peak expiratory flow (PEF) |
2.8 |
36 |
21 |
46.7 |
0.64 |
9.4e-06 |
ABO ANAPC10 ARL17B ASPSCR1 BMP4 BOK C10orf11 C1GALT1 CAMK1D CCDC87 CDC123 CTA-85E5.10 CYTL1 DCAF16 EFEMP1 FAM53A HTR4 LRRC37A2 LRRC37A4P MAP1LC3A MAPT MDM4 MRPS21 NR2F1 PSMC5 PYCR1 RNF123 RP4-614O4.11 RPS6KA1 SF3B2 SMPD2 SSH2 TCF21 TMEM194B TNFAIP8 UQCC |
Qualifications: O levels/GCSEs or equivalent |
1.2 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
DISP2 |
Blood clot in the leg (DVT) |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Medication: Paracetamol |
1.5 |
4 |
3 |
6.7 |
-1.00 |
3.6e-04 |
LRRC37A2 LRRC37A4P MAPT MLLT10 |
Headache pain in last month |
1.6 |
6 |
6 |
13.3 |
-0.76 |
1.8e-02 |
AFF1 ARL17B LRRC37A2 LRRC37A4P MAPT MRPS21 |
Medication for cholesterol, blood pressure or diabetes |
1.3 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
OPRL1 SIDT2 TCF21 |
Gout (self-reported) |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
MUC1 NFAT5 |
Hypothyroidism/myxoedema (self-reported) |
1.1 |
5 |
4 |
8.9 |
-0.99 |
4.8e-04 |
C6orf217 FKBP5 HORMAD2 SUOX TMEM194B |
Medication: Amlodipine |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CHRNB1 |
Medication: Ventolin 100micrograms inhaler |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
AAGAB |
Birth weight |
1.7 |
8 |
5 |
11.1 |
0.38 |
3.5e-01 |
ANAPC10 DCAF16 DLG4 FKBP5 HKDC1 HORMAD2 PTCH1 TULP4 |
Chronic bronchitis/emphysema (mother) |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 |
High blood pressure (siblings) |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STX1B |
Forced vital capacity (FVC), Best measure |
5.5 |
143 |
87 |
193.3 |
0.91 |
1.3e-64 |
AAGAB ABO AC073834.3 AC104532.4 ANAPC10 ANGPTL1 AOC1 AP3B1 AP4E1 ARFGEF2 ARID3B ARID5B ARL17B ARMS2 ASPSCR1 BANF1 BCDIN3D BMF BOK BRAF BTBD1 C10orf11 C2orf42 C2orf54 C6orf217 CARF CCDC126 CCDC171 CCDC87 CDC123 CENPW CEP120 CHCHD1 CHRNA3 CLIC6 CLUAP1 COG4 CPE CTA-85E5.10 CTB-36H16.2 CTC-228N24.3 CTSS CUL3 DARS DCAF16 DCXR EBPL EEF1G EFEMP1 EIF1AD EIF2AK4 EPB41L1 EPB41L2 ERC1 EYA2 FKBP5 FOXN2 FOXP1 GFAP GOLGA6L9 GRK4 HORMAD2 HTR4 INTS12 IPO8 IQCH JAG1 LMCD1 LONRF2 LRPAP1 LRRC37A2 LRRC37A4P LTBP4 MAPT MCM6 MDM4 METTL22 MICAL3 MLLT10 MRPL21 MRPS35 MST1P2 MUC1 NDUFB2 NDUFB2-AS1 NFAT5 NLRC3 NNT NOB1 NOP58 NOX4 PDIK1L PKDCC PNMT PPARD PPIAL4C PRDM11 PSMC5 PTCH1 PYCR1 PYGB QSOX2 RAB3IL1 RAVER1 RIN3 RNF123 RP11-250B2.6 RP1-137D17.1 RP11-422P24.10 RP11-613D13.5 RP11-64K12.8 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 RRP15 SCMH1 SF3B2 SHROOM3 SLC12A2 SLC25A21 SLC2A4RG SMG7 SMPD2 SMURF2 SNAI3-AS1 SNUPN SSH2 STMN3 STX1B SUOX SUSD5 TBC1D30 TCP11L1 THBS2 TULP4 UBXN2A UQCC WDR18 WNT4 ZCCHC24 ZMAT2 ZNF438 |
Body fat percentage |
2.1 |
47 |
33 |
73.3 |
-0.48 |
2.1e-04 |
AAGAB AC016725.4 AC073834.3 AIP AP3B1 ARFGEF2 C18orf8 C6orf106 CCDC171 CDK5RAP3 CENPW CHRNB1 CTC-228N24.3 CTSS DARS DCAF16 EIF3C FKBP5 FOXO3 FOXP1 GRK4 GSTP1 HOXC6 HTR4 IQCH KIAA1598 LCT LIME1 LRRC37A2 MAP2K5 MCM6 MLLT10 NFAT5 NOB1 PPARD PSMC5 PYGB RIN3 RNF123 RP11-613D13.5 RP1-283E3.4 SLC2A4RG SMAD3 SSH2 ST7L STX1B SYT14 |
Leg fat percentage (right) |
2.2 |
43 |
27 |
60.0 |
-0.58 |
8.0e-06 |
AAGAB AC016725.4 AC073834.3 ARFGEF2 C18orf8 C6orf106 CARF CCDC171 CENPW CTC-228N24.3 DARS DCAF16 DLG4 EIF3C FKBP5 FOXN2 FOXP1 GRK4 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 PPARD PSMC5 PYGB RIN3 RNF123 RP11-613D13.5 RP1-283E3.4 RP4-614O4.11 SLC12A2 SLC2A4RG SNAI3-AS1 SNUPN SSH2 STX1B SYT14 UQCC |
Arm fat-free mass (right) |
2.7 |
71 |
50 |
111.1 |
-0.30 |
9.3e-03 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 HORMAD2 IPO8 JAZF1 MAP1LC3A MLLT10 MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNUPN SNX13 STX1B SUOX TBC1D30 UBXN2A UQCC ZBTB4 |
Comparative body size at age 10 |
1.5 |
16 |
9 |
20.0 |
0.11 |
6.9e-01 |
AP3B1 ATP6V0D1 BANF1 BCDIN3D CLUAP1 DOT1L EIF3C EVI2A IQCH LIN28B MAP2K5 SEMA3B-AS1 SMG6 ST7L STX1B ZNF641 |
Worry too long after embarrassment |
1.4 |
5 |
1 |
2.2 |
-0.66 |
1.6e-01 |
BCDIN3D IQCH LRRC37A4P MAPT SYT14 |
Wheeze or whistling in the chest in last year |
1.6 |
7 |
1 |
2.2 |
-0.95 |
1.2e-03 |
BTBD7 CCDC171 CCDC46 RNF123 SLC2A4RG STMN3 STX1B |
Age at first live birth |
1.3 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
JMJD1C KIAA1598 RNF123 |
Health satisfaction |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 |
Qualifications: College or University degree |
1.4 |
19 |
15 |
33.3 |
0.63 |
2.3e-03 |
BCDIN3D C11orf80 C18orf8 CLUAP1 CTSF DPP3 EIF3C FOXO3 FOXP1 GRK4 JMJD1C LRRC37A2 LRRC37A4P MAPT MDM4 RIN1 RNF123 STMN3 SUOX |
Mouth/teeth dental problems: Loose teeth |
1.3 |
2 |
2 |
4.4 |
0.99 |
1.1e-03 |
CCDC91 RP11-967K21.1 |
Medication for pain relief, constipation, heartburn |
1.3 |
4 |
2 |
4.4 |
0.97 |
5.1e-03 |
LRRC37A2 LRRC37A4P MAPT PPARD |
Medication: Blood pressure |
1.4 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
DLG4 TCF21 |
Angina (self-reported) |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
GGT7 TCF21 |
Medication: Ibuprofen |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAPT |
Medication: Allopurinol |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
MUC1 |
Mean time to correctly identify matches |
1.3 |
8 |
2 |
4.4 |
-0.58 |
9.8e-02 |
ARFGEF2 ARL17B C11orf80 DLG4 FOXO3 RMI1 TOM1L2 WFIKKN1 |
Whole body fat mass |
2.0 |
42 |
30 |
66.7 |
-0.50 |
2.8e-04 |
AAGAB AC016725.4 AIP ANAPC10 AP3B1 C18orf8 C6orf106 CCDC171 CDK5RAP3 CEP120 CTD-2201E18.3 EFEMP1 EIF3C EPB41L1 FKBP5 FOXO3 FOXP1 GGT7 GRK4 GSTP1 HTR4 IQCH KIAA1598 LCT MAP1LC3A MAP2K5 MCM6 MLLT10 NFAT5 NOB1 NR3C1 PPARD PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SLC2A4RG SMAD3 SSH2 STX1B SYT14 UQCC |
Leg fat mass (right) |
1.8 |
33 |
23 |
51.1 |
-0.53 |
5.9e-04 |
AAGAB AC016725.4 AIP AP3B1 C18orf8 C6orf106 CCDC171 CDK5RAP3 CTC-228N24.3 CTD-2201E18.3 EIF3C FKBP5 FOXO3 FOXP1 GGT7 GRK4 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SLC2A4RG SSH2 STX1B SYT14 |
Arm predicted mass (right) |
2.7 |
68 |
52 |
115.6 |
-0.32 |
5.4e-03 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 B3GNT7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 HORMAD2 JAZF1 MAP1LC3A MLLT10 MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNUPN SNX13 STX1B SUOX UBXN2A UQCC ZBTB4 |
Pulse rate, automated reading |
1.4 |
14 |
9 |
20.0 |
-0.41 |
1.1e-01 |
B3GNT7 BTBD1 C6orf106 CD55 CEP120 DARS EEF1G EIF2AK4 MSH6 NFAT5 PDIK1L TCF21 TMEM194B TOM1L2 |
Alcohol intake frequency. |
1.5 |
14 |
9 |
20.0 |
-0.65 |
9.0e-03 |
ADH1B C18orf8 CDADC1 EIF3C EVI2A FOXP1 LEAP2 LRRC37A2 LRRC37A4P MAPT NFAT5 NOA1 SMPD2 TCF4 |
Comparative height size at age 10 |
3.4 |
90 |
67 |
148.9 |
-0.12 |
2.3e-01 |
AAGAB AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARL17B ARMS2 ATOH7 B3GNT7 BANF1 BCDIN3D BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC126 CCDC91 CENPW CEP120 CHRNB1 CHRNG CLUAP1 CNIH4 CNTROB COPS7B CPE CPNE1 CRLF3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FLI1 FOXO3 GGT7 HKDC1 HORMAD2 IQCH JAZF1 LRRC37A2 LRRC37A4P MAP1LC3A MAPT MICAL3 MRPS6 MST1P2 NR3C1 P4HA2 PBLD PDIK1L PIEZO1 PPIAL4C PSMC5 PTCH1 PYCR1 QSOX2 RAB7L1 RAVER1 RBBP8 RMI1 RP11-171I2.2 RP11-477D19.2 RP11-529H20.5 RP11-967K21.1 RP1-199J3.5 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SMPD2 SUSD5 TCF4 TRAF3IP1 TULP4 UBXN2A UQCC WFIKKN1 WNT4 WWOX ZBTB4 |
Suffer from 'nerves' |
1.2 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
EIF3C |
Overall health rating |
1.4 |
7 |
4 |
8.9 |
-0.96 |
7.9e-04 |
CCDC87 DCAF16 FOXP1 GRK4 HTR4 RNF123 STX1B |
Age at last live birth |
1.0 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RNF123 |
Knee pain experienced in last month |
1.4 |
3 |
1 |
2.2 |
0.86 |
1.4e-01 |
FAM53A STX1B UQCC |
Hypertension (Self-reported) |
1.5 |
11 |
5 |
11.1 |
-0.34 |
3.1e-01 |
CHRNB1 DCAF16 DLG4 GCHFR HOXC6 HTR4 MAP2K5 NAT15 OPRL1 SLC12A2 STX1B |
Illnesses of father: Heart disease |
1.2 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF21 |
Illnesses of siblings: Diabetes |
1.2 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CAMK1D |
Smoking status: Previous |
1.6 |
1 |
1 |
2.2 |
0.09 |
9.1e-01 |
MSH6 |
Forced expiratory volume in 1-second (FEV1), predicted |
2.6 |
31 |
24 |
53.3 |
-0.45 |
7.9e-03 |
ANAPC10 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CHRNB1 CNIH4 CRLF3 DCAF16 DIS3L2 DOT1L EFEMP1 EPB41L1 GGT7 JAZF1 LIN28B LTBP1 MAP1LC3A MST1P2 PTCH1 RP11-529H20.5 RP11-967K21.1 RP4-614O4.11 SCMH1 SEMA3B-AS1 UQCC ZBTB4 |
Whole body fat-free mass |
2.9 |
78 |
63 |
140.0 |
-0.19 |
8.7e-02 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 B3GNT7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 HORMAD2 IPO8 JAZF1 KIAA1598 MAP1LC3A MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 QSOX2 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC12A2 SLC25A5P1 SMPD2 SNAI3-AS1 SNUPN STX1B SUOX TULP4 UBXN2A UQCC WNT4 ZBTB4 ZMAT2 |
Leg fat-free mass (right) |
2.7 |
72 |
48 |
106.7 |
-0.13 |
2.7e-01 |
AC062029.1 ACTG1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CDK5RAP3 CENPW CEP120 CHRNB1 CLUAP1 CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 GLB1 HORMAD2 IPO8 IQCH KIAA1598 MAP1LC3A MRPL21 MUC1 NR2F1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-90P5.2 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SLC12A2 SMPD2 SMURF2 SNAI3-AS1 STX1B SUOX SUPT3H TULP4 UQCC WNT4 ZSWIM7 |
Arm fat percentage (left) |
1.9 |
39 |
29 |
64.4 |
-0.36 |
1.4e-02 |
AAGAB ABO AC016725.4 AP3B1 ARFGEF2 C17orf82 C18orf8 C6orf106 CCDC171 CCDC87 CDK5RAP3 CENPW CHRNB1 DCAF16 DLG4 EIF3C FKBP5 FOXP1 GRK4 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 NOP58 PPARD PYGB RNF123 RP11-613D13.5 RP11-967K21.1 RP1-283E3.4 SMAD3 SSH2 STX1B SYT14 |
Average weekly red wine intake |
1.3 |
4 |
2 |
4.4 |
0.99 |
1.2e-02 |
C18orf8 CTSF FOXP1 SLC29A2 |
Handedness (chirality/laterality): Left-handed |
1.5 |
5 |
4 |
8.9 |
0.79 |
3.4e-02 |
ARL17B LRRC37A2 LRRC37A4P MAP2 MAPT |
Mood swings |
1.5 |
7 |
6 |
13.3 |
-0.87 |
4.4e-03 |
ARL17B DCC LRRC37A2 LRRC37A4P MAPT RNF123 TCF4 |
Long-standing illness, disability or infirmity |
1.7 |
5 |
1 |
2.2 |
-0.43 |
4.0e-01 |
CCDC171 IQCH NFAT5 NR2F1 RNF123 |
Diabetes diagnosed by doctor |
1.6 |
4 |
3 |
6.7 |
-0.99 |
6.0e-03 |
CAMK1D JAZF1 NFAT5 ZCCHC24 |
Mouth/teeth dental problems: Mouth ulcers |
1.3 |
4 |
3 |
6.7 |
-0.76 |
1.3e-01 |
CTSS LRRC37A2 LRRC37A4P MAPT |
Back pain experienced in last month |
1.4 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARMS2 C6orf106 SMAD3 |
Asthma (self-reported) |
1.7 |
11 |
8 |
17.8 |
0.01 |
9.8e-01 |
AAGAB C6orf217 HTR4 IQCH MAP2K5 P4HA2 PNMT RIN3 SLC2A4RG STMN3 SUOX |
Osteoarthritis (self-reported) |
1.3 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FAM53A RAVER1 |
Smoking status: Current |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
STMN3 |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
4.8 |
46 |
25 |
55.6 |
0.96 |
1.6e-29 |
ALDH6A1 ANGPTL1 ARL17B ASPSCR1 BMP6 BTBD1 C10orf11 CAMK1D CCDC91 CDC123 CEP120 CHCHD1 CHRNA3 CTA-85E5.10 CTSS DISP2 EEF1G GOLGA6L9 HM13 HTR4 INTS12 JAG1 LLGL2 LRRC37A2 LRRC37A4P MAP2 MAPT MICAL3 NNT NOB1 PDIK1L PLAGL2 PNMT PYGB QSOX2 RIN3 RNF123 RP11-541N10.3 RP11-967K21.1 SLC2A4RG SLMAP SOGA2 STMN3 STX1B UQCC WNT4 |
Whole body water mass |
2.9 |
78 |
64 |
142.2 |
-0.18 |
9.3e-02 |
AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 B3GNT7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 HORMAD2 IPO8 KIAA1598 MAP1LC3A MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 QSOX2 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC12A2 SLC25A5P1 SMPD2 SNAI3-AS1 SNUPN SNX13 STX1B SUOX TULP4 UBXN2A UQCC WNT4 ZBTB4 ZMAT2 |
Leg predicted mass (right) |
2.7 |
72 |
48 |
106.7 |
-0.13 |
2.7e-01 |
AC062029.1 ACTG1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CDK5RAP3 CENPW CEP120 CHRNB1 CLUAP1 CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 GLB1 HORMAD2 IPO8 IQCH KIAA1598 MAP1LC3A MRPL21 MUC1 NR2F1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-90P5.2 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SLC12A2 SMPD2 SMURF2 SNAI3-AS1 STX1B SUOX SUPT3H TULP4 UQCC WNT4 ZSWIM7 |
Arm fat mass (left) |
1.8 |
38 |
24 |
53.3 |
-0.57 |
7.0e-05 |
AAGAB AC016725.4 AP3B1 BTBD7 C18orf8 C6orf106 CCDC171 CDK5RAP3 CEP120 CLUAP1 DLG4 EIF3C EPB41L1 FOXO3 FOXP1 GGT7 GRK4 HTR4 IQCH KIAA1598 LCT MAP1LC3A MAP2K5 MCM6 MLLT10 NFAT5 NLRC3 NOB1 NR2F1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SMAD3 STX1B SYT14 UQCC ZSWIM7 |
Number of self-reported non-cancer illnesses |
1.7 |
8 |
4 |
8.9 |
0.04 |
9.0e-01 |
AAGAB CCDC87 IQCH MAP2K5 NFAT5 OPRL1 RNF123 STMN3 |
Average weekly champagne plus white wine intake |
1.2 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A2 LRRC37A4P MAPT |
Miserableness |
1.3 |
5 |
5 |
11.1 |
-0.94 |
5.4e-03 |
LRRC37A2 LRRC37A4P MAPT RNF123 TCF4 |
Guilty feelings |
1.4 |
5 |
2 |
4.4 |
-0.77 |
7.5e-02 |
LIN28B LRRC37A2 LRRC37A4P MAPT UBXN2A |
Financial situation satisfaction |
1.1 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 |
Medication: Blood pressure |
1.4 |
6 |
0 |
0.0 |
0.70 |
1.2e-01 |
C1GALT1 HOXC6 LRRC37A2 LRRC37A4P MAPT P4HA2 |
Supplements: Fish oil (including cod liver oil) |
1.3 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 NFAT5 |
High cholesterol (Self-reported) |
1.5 |
7 |
5 |
11.1 |
-0.74 |
5.6e-02 |
ABO APOC1P1 CARF NOP58 OPRL1 SIDT2 TSEN2 |
Medication: Bendroflumethiazide |
1.3 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF21 |
Medication: Paracetamol |
1.4 |
3 |
3 |
6.7 |
-1.00 |
1.3e-03 |
LRRC37A2 LRRC37A4P MAPT |
Ever smoked |
1.5 |
2 |
1 |
2.2 |
0.08 |
9.0e-01 |
MSH6 ZFHX3 |
Basal metabolic rate |
2.7 |
74 |
55 |
122.2 |
-0.25 |
2.7e-02 |
AC004540.4 AC062029.1 ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CDK5RAP3 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 CTC-228N24.3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 HORMAD2 IPO8 IQCH KIAA1598 MAP1LC3A MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SDCCAG3 SENP6 SLC12A2 SLC25A5P1 SMPD2 STX1B SUOX TULP4 UBXN2A UQCC WNT4 ZBTB4 ZMAT2 |
Leg fat percentage (left) |
2.2 |
44 |
27 |
60.0 |
-0.60 |
3.7e-06 |
AAGAB AC016725.4 AC073834.3 AIP ARFGEF2 C18orf8 C6orf106 CARF CCDC171 CENPW CTC-228N24.3 DARS DCAF16 EIF3C FKBP5 FOXN2 FOXO3 FOXP1 GRK4 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 PPARD PSMC5 PYGB RIN3 RNF123 RP11-613D13.5 RP1-283E3.4 RP4-614O4.11 SLC12A2 SLC2A4RG SSH2 STMN3 STX1B SYT14 UQCC ZCCHC24 |
Arm fat-free mass (left) |
2.7 |
67 |
52 |
115.6 |
-0.32 |
6.4e-03 |
ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 DCAF16 DIS3L2 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GGT7 HORMAD2 KIAA1598 MAP1LC3A MLLT10 MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 RPS6KA1 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNX13 STX1B SUOX UBXN2A UQCC ZBTB4 |
Number of operations (self-reported) |
1.5 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CTC-228N24.3 MLLT10 PARK7 |
Average weekly beer plus cider intake |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
JMJD1C RNF123 |
Irritability |
1.4 |
4 |
3 |
6.7 |
-0.99 |
7.6e-04 |
KLRAQ1 LRRC37A2 LRRC37A4P MAPT |
Fractured/broken bones in last 5 years |
1.4 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
IQCH |
Diastolic blood pressure, automated reading |
1.4 |
21 |
10 |
22.2 |
-0.39 |
8.1e-02 |
ABO AC016725.4 ADAMTS8 CEP120 DARS DCAF16 DLG4 GCHFR JAG1 LIME1 MICAL3 RNF123 RP11-23P13.7 SCMH1 SLC2A4RG SLMAP SMG6 STMN3 STX1B THBS2 TMEM194B |
Myopia |
1.3 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
BMP4 QSOX2 |
Vascular/heart problems diagnosed by doctor |
1.4 |
11 |
6 |
13.3 |
0.29 |
3.8e-01 |
C1GALT1 CHRNB1 DCAF16 DLG4 GCHFR HOXC6 IQCH MAP2K5 OPRL1 STX1B TCF21 |
Cholesterol lowering medication |
1.4 |
5 |
0 |
0.0 |
-0.99 |
1.7e-03 |
ABO CARF OPRL1 SIDT2 STX1B |
Pain experienced in last month |
1.4 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CENPW STX1B |
Heart attack/myocardial infarction (self-reported) |
1.2 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF21 TOM1L2 |
Deep venous thrombosis (DVT) (self-reported) |
1.4 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ABO |
Pack years of smoking |
1.6 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CHRNA3 JMJD1C |
Impedance of whole body |
1.9 |
58 |
44 |
97.8 |
-0.10 |
4.4e-01 |
AOC1 ARL17B C11orf80 C6orf106 CENPW CEP120 CERS2 CLUAP1 CPNE1 CTC-228N24.3 CTSF CTSS DIP2B DPP3 EEF1G EFEMP1 EPB41L1 EVI2A FLJ12825 FOXO3 GGT7 HLX HOXC6 JAZF1 JMJD1C JPH2 LIME1 LIN28B LRRC37A2 LRRC37A4P LRRN2 LTBP1 MAP1LC3A MAPT MRPL21 MST1P2 MUC1 NLRC3 NOL8 NUFIP2 PIAS1 PNMAL1 PSMC5 RAVER1 RIN1 RIN3 RMI1 RNF123 RPS20 SCMH1 SEMA3B-AS1 SLC12A2 SLC2A4RG STX1B SUOX SUPT3H UQCC ZNF641 |
Leg fat mass (left) |
1.8 |
36 |
23 |
51.1 |
-0.56 |
1.2e-04 |
AAGAB AC016725.4 AIP AP3B1 BTBD7 C18orf8 C6orf106 CCDC171 CDK5RAP3 CTC-228N24.3 CTD-2201E18.3 DARS EIF3C FKBP5 FOXO3 FOXP1 GGT7 GRK4 GSTP1 HTR4 IQCH KIAA1598 LCT MAP2K5 MCM6 MLLT10 NFAT5 NOB1 PYGB RNF123 RP11-613D13.5 RP1-283E3.4 SLC2A4RG SSH2 STX1B SYT14 |
Arm predicted mass (left) |
2.6 |
67 |
51 |
113.3 |
-0.30 |
1.0e-02 |
ANAPC10 AOC1 AP3B1 ARFGEF2 ARMS2 ATOH7 BMP6 BOK C17orf82 C18orf8 C6orf106 CCDC91 CENPW CEP120 CHP CHRNB1 CHRNG CNIH4 COPS7B CPNE1 CRLF3 DCAF16 DOT1L EBPL EFEMP1 EIF2AK4 EIF3C EPB41L1 EVI2A FAM53A FOXO3 GFAP GGT7 HORMAD2 KIAA1598 MAP1LC3A MLLT10 MRPL21 MUC1 NR3C1 P4HA2 PARK7 PBLD PDIK1L PNMAL1 PSMC5 PTCH1 RAB7L1 RAVER1 RIN3 RNF123 RP11-613D13.5 RP11-967K21.1 RP4-614O4.11 RPS20 SCMH1 SDCCAG3 SENP6 SLC25A5P1 SMPD2 SNUPN STX1B SUOX UBXN2A UQCC ZBTB4 ZMAT2 |